DHR vs UNH: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+97.1% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+97.1%).
UNH trades at a lower forward P/E
(26.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
UNH |
| Current Price |
$174.04 |
$353.52 |
| Fair Value Estimate |
$197.01 |
$696.88 |
| Upside to Fair Value |
+13.2%
|
+97.1%
|
| Market Cap |
$123.2B |
$320.9B |
| Forward P/E |
33.4x
|
26.7x
|
| EV / EBITDA |
20.3x
|
16.1x
|
| Price / Sales |
5.0x
|
0.7x
|
| Price / FCF |
23.3x
|
16.3x
|
| Revenue Growth YoY |
+3.7%
|
+2.0%
|
| Gross Margin |
60.7%
|
18.8%
|
| Operating Margin |
21.0%
|
4.2%
|
| Return on Equity |
7.1%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
6.13%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
DHR |
UNH |
| Zone Low |
$147.76 |
$522.66 |
| Zone High |
$167.46 |
$592.35 |
| In Buy Zone? |
No
|
Yes
|